News for ProMIS Neurosciences, Inc. (23J.F)

Published at

Jan 14, 2021 12:30 AM

by benzinga.com

positive

positive

Multiple System Atrophy Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade

Los Angeles, USA, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Multiple System Atrophy Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade Multiple ...

VYGR.MX VYGR VT6.SG VT6.F PRNAF PMN.TO PBNN.SG PBNN.F PBN.SG PBN.F NWRN.SW NP5.F NP5.DE LDB.SG LDB.MU LDB.F LDB.BE IKT HLUKF ATHE ATH.AX ARFXF 23J.F 23J.BE

Read more →
Published at

Jan 4, 2021 2:30 PM

by benzinga.com

positive

positive

Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer

AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA) a clinical-stage biotechnology company focused on Alzheimer's disease, ...

SAVA PX91.MU PX91.F PX91.BE PMN.TO ARFXF 23J.F 23J.BE

Read more →